Invitae Corporation (NVTA) |
|
2.44 -0.12 (-4.69%)
|
09-24 16:11 |
|
Open: |
2.43 |
Pre. Close: |
2.56 |
|
High:
|
2.525 |
Low:
|
2.37 |
|
Volume:
|
6,310,684 |
Market Cap:
|
574(M) |
|
|
|
|
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.54 - 2.56 |
2.56 - 2.58 |
|
Low:
|
2.32 - 2.35 |
2.35 - 2.37 |
|
Close:
|
2.4 - 2.46 |
2.46 - 2.49 |
|
Technical analysis |
as of: 2022-09-23 4:26:20 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 4.08  One year: 4.9 |
| Support: |
Support1: 2.36 Support2: 1.97 |
| Resistance: |
Resistance1: 3.5 Resistance2: 4.19 |
| Pivot: |
3.16 |
| Moving Average: |
MA(5): 2.76 MA(20): 3.12
MA(100): 3.12 MA(250): 9.85 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.1 |
| Stochastic oscillator: |
%K(14,3): 5.5 %D(3): 12 |
| RSI: |
RSI(14): 39.5 |
| 52-week: |
High: 29.14 Low: 1.83 |
| Average Vol(K): |
3-Month: 19,045 (K) 10-Days: 9,349 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ NVTA ] has closed above bottom band by 10.2%. Bollinger Bands are 24.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 23 Sep 2022
Invitae (NYSE:NVTA) Upgraded to Sell at StockNews.com - MarketBeat
Thu, 22 Sep 2022
Opinion: NVTA regional transportation plan unaffordable and ineffective - PotomacLocal.com
Thu, 22 Sep 2022
CA: Napa Vine debuts electric bus in Yountville - Mass Transit Magazine
Thu, 15 Sep 2022
Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer - PR Newswire
Tue, 13 Sep 2022
Invitae Corporation (NVTA) Morgan Stanley 20th Annual Global Healthcare Conference Transcript - Seeking Alpha
Mon, 12 Sep 2022
Is Invitae Corp (NVTA) Stock About to Get Hot Monday? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Neutral |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
226 (M) |
| Shares Float |
215 (M) |
|
% Held by Insiders
|
1.2 (%) |
|
% Held by Institutions
|
81.3 (%) |
|
Shares Short
|
50,430 (K) |
|
Shares Short P.Month
|
50,290 (K) |
Stock Financials |
|
EPS
|
-4.48 |
|
EPS Est Next Qtl
|
-0.51 |
|
EPS Est This Year
|
-2.35 |
|
EPS Est Next Year
|
-1.34 |
|
Book Value (p.s.)
|
10.63 |
|
Profit Margin (%)
|
-94 |
|
Operating Margin (%)
|
-169 |
|
Return on Assets (ttm)
|
-11.8 |
|
Return on Equity (ttm)
|
-17.3 |
|
Qtrly Rev. Growth
|
19.3 |
|
Gross Profit (p.s.)
|
0.49 |
|
Sales Per Share
|
2.12 |
|
EBITDA (p.s.)
|
-3.19 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-618 (M) |
|
Levered Free Cash Flow
|
-358 (M) |
Stock Valuations |
|
PE Ratio
|
-0.55 |
|
PEG Ratio
|
-0.1 |
|
Price to Book value
|
0.22 |
|
Price to Sales
|
1.14 |
|
Price to Cash Flow
|
-0.9 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
